| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 3.43e-06 | 30 | 157 | 5 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 3.43e-06 | 30 | 157 | 5 | GO:0097472 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | TNIK CDK16 CDK17 CAMK4 RPS6KA3 LMTK2 CDK11A DYRK4 CDK14 PIM3 RPS6KA6 ULK4 CDK4 | 6.15e-06 | 363 | 157 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TNIK CDK16 CDK17 PANK3 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A DYRK4 CDK14 PIM3 PANK2 RNASEL RPS6KA6 ULK4 CDK4 | 1.23e-05 | 709 | 157 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TNIK CDK16 CDK17 PANK3 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A FPGT DYRK4 CDK14 PIM3 PANK2 RNASEL RPS6KA6 PCYT2 ULK4 POLN CDK4 | 1.50e-05 | 938 | 157 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | TNIK CDK16 CDK17 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A DYRK4 CDK14 PIM3 RNASEL RPS6KA6 ULK4 CDK4 | 2.13e-05 | 600 | 157 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | TNIK CDK16 CDK17 PANK3 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A DYRK4 CDK14 PIM3 PANK2 RNASEL RPS6KA6 ULK4 CDK4 | 3.31e-05 | 764 | 157 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TNIK CDK16 CDK17 CAMK4 RPS6KA3 LMTK2 CDK11A DYRK4 CDK14 PIM3 RPS6KA6 ULK4 CDK4 | 5.33e-05 | 446 | 157 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | UDP-glucose:glycoprotein glucosyltransferase activity | 6.14e-05 | 2 | 157 | 2 | GO:0003980 | |
| GeneOntologyMolecularFunction | MHC protein binding | 9.23e-05 | 58 | 157 | 5 | GO:0042287 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.11e-04 | 32 | 157 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | pantothenate kinase activity | 3.65e-04 | 4 | 157 | 2 | GO:0004594 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 6.05e-04 | 5 | 157 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 6.05e-04 | 5 | 157 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.29e-04 | 188 | 157 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 9.03e-04 | 6 | 157 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 9.03e-04 | 6 | 157 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 1.26e-03 | 7 | 157 | 2 | GO:0023025 | |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 1.26e-03 | 7 | 157 | 2 | GO:0004711 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.27e-03 | 102 | 157 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | lyase activity | 1.47e-03 | 212 | 157 | 7 | GO:0016829 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 1.67e-03 | 8 | 157 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.67e-03 | 8 | 157 | 2 | GO:0032453 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 6.84e-06 | 62 | 154 | 6 | GO:0035306 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 1.66e-05 | 43 | 154 | 5 | GO:0071711 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar metabolic process | 1.87e-05 | 44 | 154 | 5 | GO:0009225 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 5.53e-05 | 130 | 154 | 7 | GO:0097306 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 5.53e-05 | 130 | 154 | 7 | GO:1901655 | |
| GeneOntologyBiologicalProcess | UDP-glucosylation | 5.54e-05 | 2 | 154 | 2 | GO:0097359 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | COL6A1 PANK3 UGGT1 INSR SHMT1 HMGCS1 ADCY3 ADCY8 PGM1 PANK2 TGDS GMDS UGGT2 HSD11B1 CSGALNACT1 ATP5F1A MVD | 6.19e-05 | 767 | 154 | 17 | GO:0055086 |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | GPLD1 COL6A1 PANK3 B3GNT5 PDGFRB UGGT1 INSR SHMT1 HMGCS1 ADCY3 ADCY8 PGM1 PANK2 GANAB TGDS GMDS UGGT2 ALDH1A1 HSD11B1 CSGALNACT1 ATP5F1A MVD | 1.17e-04 | 1226 | 154 | 22 | GO:1901135 |
| GeneOntologyBiologicalProcess | response to ketone | 1.27e-04 | 254 | 154 | 9 | GO:1901654 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 1.40e-04 | 14 | 154 | 3 | GO:1900454 | |
| GeneOntologyBiologicalProcess | centromeric sister chromatid cohesion | 1.40e-04 | 14 | 154 | 3 | GO:0070601 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 7.10e-06 | 17 | 159 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL6A1 COL12A1 TNC UGGT1 LAMC1 APOA1 F5 PDIA3 GANAB MTTP TXNDC16 UGGT2 | 9.35e-06 | 332 | 159 | 12 | GO:0005788 |
| GeneOntologyCellularComponent | tertiary granule | 2.65e-04 | 164 | 159 | 7 | GO:0070820 | |
| GeneOntologyCellularComponent | tenascin complex | 3.42e-04 | 4 | 159 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | basement membrane | 3.44e-04 | 122 | 159 | 6 | GO:0005604 | |
| Domain | PROTEIN_KINASE_ATP | TNIK CDK16 CDK17 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A DYRK4 CDK14 PIM3 RNASEL RPS6KA6 ULK4 CDK4 | 1.68e-06 | 459 | 157 | 16 | PS00107 |
| Domain | Kinase-like_dom | TNIK CDK16 CDK17 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A ARHGAP35 DYRK4 CDK14 PIM3 RNASEL RPS6KA6 ULK4 CDK4 | 3.28e-06 | 542 | 157 | 17 | IPR011009 |
| Domain | Prot_kinase_dom | TNIK CDK16 CDK17 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A DYRK4 CDK14 PIM3 RNASEL RPS6KA6 ULK4 CDK4 | 3.80e-06 | 489 | 157 | 16 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TNIK CDK16 CDK17 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 CDK11A DYRK4 CDK14 PIM3 RNASEL RPS6KA6 ULK4 CDK4 | 4.21e-06 | 493 | 157 | 16 | PS50011 |
| Domain | Protein_kinase_ATP_BS | TNIK CDK16 CDK17 PDGFRB CAMK4 RPS6KA3 INSR LMTK2 DYRK4 CDK14 PIM3 RPS6KA6 CDK4 | 1.96e-05 | 379 | 157 | 13 | IPR017441 |
| Domain | Pkinase | TNIK CDK16 CDK17 CAMK4 RPS6KA3 CDK11A DYRK4 CDK14 PIM3 RNASEL RPS6KA6 ULK4 CDK4 | 2.07e-05 | 381 | 157 | 13 | PF00069 |
| Domain | Growth_fac_rcpt_ | 5.28e-05 | 156 | 157 | 8 | IPR009030 | |
| Domain | S_TKc | TNIK CDK16 CDK17 CAMK4 RPS6KA3 CDK11A DYRK4 CDK14 PIM3 RNASEL RPS6KA6 CDK4 | 5.31e-05 | 359 | 157 | 12 | SM00220 |
| Domain | PROTEIN_KINASE_ST | TNIK CDK16 CDK17 CAMK4 RPS6KA3 CDK11A DYRK4 CDK14 PIM3 RPS6KA6 ULK4 CDK4 | 5.75e-05 | 362 | 157 | 12 | PS00108 |
| Domain | UDP-g_GGtrans | 7.02e-05 | 2 | 157 | 2 | IPR009448 | |
| Domain | UDP-g_GGTase | 7.02e-05 | 2 | 157 | 2 | PF06427 | |
| Domain | G2F | 2.09e-04 | 3 | 157 | 2 | SM00682 | |
| Domain | Ser/Thr_kinase_AS | TNIK CDK16 CDK17 CAMK4 RPS6KA3 CDK11A DYRK4 CDK14 PIM3 RPS6KA6 CDK4 | 2.22e-04 | 357 | 157 | 11 | IPR008271 |
| Domain | Lys_sp_deMease-like_dom | 4.17e-04 | 4 | 157 | 2 | IPR013637 | |
| Domain | G2F | 4.17e-04 | 4 | 157 | 2 | PF07474 | |
| Domain | Type_II_PanK | 4.17e-04 | 4 | 157 | 2 | IPR004567 | |
| Domain | GDP_Man_Dehyd | 4.17e-04 | 4 | 157 | 2 | PF16363 | |
| Domain | NIDOGEN_G2 | 4.17e-04 | 4 | 157 | 2 | PS50993 | |
| Domain | GFP | 4.17e-04 | 4 | 157 | 2 | IPR009017 | |
| Domain | PLU-1 | 4.17e-04 | 4 | 157 | 2 | PF08429 | |
| Domain | Fumble | 4.17e-04 | 4 | 157 | 2 | PF03630 | |
| Domain | G2_nidogen/fibulin_G2F | 4.17e-04 | 4 | 157 | 2 | IPR006605 | |
| Domain | fn3 | 4.45e-04 | 162 | 157 | 7 | PF00041 | |
| Domain | Groucho_enhance | 6.91e-04 | 5 | 157 | 2 | IPR009146 | |
| Domain | TLE_N | 6.91e-04 | 5 | 157 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 6.91e-04 | 5 | 157 | 2 | IPR005617 | |
| Domain | zf-C5HC2 | 6.91e-04 | 5 | 157 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 6.91e-04 | 5 | 157 | 2 | IPR004198 | |
| Domain | - | 6.93e-04 | 21 | 157 | 3 | 3.30.230.10 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 7.98e-04 | 22 | 157 | 3 | IPR014721 | |
| Domain | EGF | 8.54e-04 | 235 | 157 | 8 | SM00181 | |
| Domain | Ig-like_fold | LILRA2 COL12A1 MYOM1 PDGFRB TNC LILRB2 INSR FNDC7 FCAR PXDN HMCN1 UMODL1 TNN CD274 LSAMP | 9.17e-04 | 706 | 157 | 15 | IPR013783 |
| Domain | FN3 | 9.77e-04 | 185 | 157 | 7 | SM00060 | |
| Domain | Ribosomal_S6_kinase_II | 1.03e-03 | 6 | 157 | 2 | IPR016239 | |
| Domain | EGF-like_dom | 1.24e-03 | 249 | 157 | 8 | IPR000742 | |
| Domain | Epimerase_deHydtase | 1.43e-03 | 7 | 157 | 2 | IPR001509 | |
| Domain | Epimerase | 1.43e-03 | 7 | 157 | 2 | PF01370 | |
| Domain | - | LILRA2 COL12A1 MYOM1 PDGFRB TNC INSR FNDC7 FCAR PXDN HMCN1 UMODL1 TNN CD274 LSAMP | 1.44e-03 | 663 | 157 | 14 | 2.60.40.10 |
| Domain | EGF_1 | 1.44e-03 | 255 | 157 | 8 | PS00022 | |
| Domain | FN3 | 1.49e-03 | 199 | 157 | 7 | PS50853 | |
| Domain | EGF-like_CS | 1.67e-03 | 261 | 157 | 8 | IPR013032 | |
| Domain | EGF_2 | 1.83e-03 | 265 | 157 | 8 | PS01186 | |
| Domain | AC_N | 1.90e-03 | 8 | 157 | 2 | IPR032628 | |
| Domain | Adcy | 1.90e-03 | 8 | 157 | 2 | IPR030672 | |
| Domain | Disulphide_isomerase | 1.90e-03 | 8 | 157 | 2 | IPR005788 | |
| Domain | AC_N | 1.90e-03 | 8 | 157 | 2 | PF16214 | |
| Domain | FN3_dom | 1.97e-03 | 209 | 157 | 7 | IPR003961 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 6.03e-05 | 80 | 120 | 6 | M223 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 6.46e-05 | 26 | 120 | 4 | M907 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 8.48e-05 | 85 | 120 | 6 | M27079 | |
| Pubmed | CMBL CDK16 CDK17 NAA10 PSMC5 PSMD2 HMGCS1 CDK14 PDIA3 TBCB GET4 GANAB UBE3A LTA4H TMX3 ATP5F1A MVD CDK4 | 1.39e-07 | 878 | 160 | 18 | 37223481 | |
| Pubmed | 2.07e-07 | 12 | 160 | 4 | 19884882 | ||
| Pubmed | 2.99e-07 | 13 | 160 | 4 | 18303019 | ||
| Pubmed | 5.19e-07 | 64 | 160 | 6 | 22261194 | ||
| Pubmed | PANK3 B3GNT5 RPS6KA3 UGGT1 ESRP1 TTC14 LMTK2 SHMT1 CHD3 FAM171B ADCY3 PGM1 C5orf34 TLE4 DZIP3 CPSF2 TMX3 KIF13A ATP5F1A | 6.65e-07 | 1084 | 160 | 19 | 11544199 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DNAJB12 COL6A1 COL12A1 UGGT1 LAMC1 PSMD2 GRIK2 PDIA3 ITPR2 FAT1 GANAB PXDN TXNDC16 NID1 PLEKHA5 UGGT2 SLC39A14 CPSF2 TMX3 CSGALNACT1 | 7.32e-07 | 1201 | 160 | 20 | 35696571 |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | CUL1 ZBTB17 PDGFRB CAMK4 RPS6KA3 CDK11A DYRK4 CDK14 PIM3 RPS6KA6 CDK4 | 1.36e-06 | 372 | 160 | 11 | 22939624 |
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 9824165 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 24040397 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 29482582 | ||
| Pubmed | 2.43e-06 | 21 | 160 | 4 | 32731332 | ||
| Pubmed | 3.47e-06 | 50 | 160 | 5 | 23658023 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL1 MYL6 RNASEH2A RPS6KA3 UGGT1 NAA10 SHMT1 SH3GLB2 PSMC5 PSMD2 PFDN5 PDIA3 TBCB GET4 GANAB SH2D4A UBE3A PCYT2 GMDS KIF13A MVD | 3.64e-06 | 1455 | 160 | 21 | 22863883 |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 4.31e-06 | 141 | 160 | 7 | 32322062 | |
| Pubmed | 4.52e-06 | 142 | 160 | 7 | 30809309 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CMBL COL6A1 CAMK4 SHMT1 PSMC5 LAMC1 APOA1 CR1 PGM1 PTPN6 FAT1 GANAB HP NID1 LTA4H ALDH1A1 ATP5F1A | 4.95e-06 | 1016 | 160 | 17 | 19056867 |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 1639063 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 21376641 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DNAJB12 CUL1 RPL35A MYL6 RNASEH2A UGGT1 SHMT1 PSMC5 PSMD2 GET4 GANAB UBE3A KLHL21 GMDS CPSF2 TMX3 GFM1 ATP5F1A CDK4 | 5.74e-06 | 1257 | 160 | 19 | 37317656 |
| Pubmed | KRT2 UGGT1 CEP290 LMTK2 PSMC5 PSMD2 FAM171B PDIA3 ITPR2 PTPN6 GANAB SH2D4A MLH1 MICAL3 TANC1 CPSF2 ATP5F1A | 7.51e-06 | 1049 | 160 | 17 | 27880917 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 7.62e-06 | 101 | 160 | 6 | 20551380 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CMBL CUL1 CDK17 RPL35A MYL6 UGGT1 PSMC5 PSMD2 CDK14 TCHH PANK2 GET4 LOXHD1 GANAB SH2D4A LTA4H CPSF2 PREX1 CDK4 | 7.75e-06 | 1284 | 160 | 19 | 17353931 |
| Pubmed | DNAJB12 KRT2 RPL35A MYL6 PDGFRB CEP290 NAA10 PSMC5 PSMD2 F5 ADCY3 ITPR2 GANAB MLH1 PLEKHA5 HSD11B1 CPSF2 ATP5F1A | 7.92e-06 | 1168 | 160 | 18 | 19946888 | |
| Pubmed | TNIK DNAJB12 KRT2 COL12A1 MYL6 UGGT1 NAA10 PSMC5 LAMC1 PSMD2 PDIA3 FAT1 GANAB PXDN MLH1 UGGT2 SLC39A14 TMX3 ATP5F1A | 8.93e-06 | 1297 | 160 | 19 | 33545068 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | GPLD1 KRT2 COL6A1 MYL6 SHMT1 LAMC1 APOA1 CR1 PGM1 GANAB PXDN HMCN1 HP NID1 LTA4H ALDH1A1 ATP5F1A | 9.71e-06 | 1070 | 160 | 17 | 23533145 |
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 1.12e-05 | 10 | 160 | 3 | 18802077 | |
| Pubmed | Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. | 1.12e-05 | 10 | 160 | 3 | 29160310 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RPL35A RPS6KA3 UGGT1 PSMC5 LAMC1 PSMD2 APOA1 PFDN5 PDIA3 PTPN6 GET4 GANAB TXNDC16 NID1 TMX3 GFM1 | 1.20e-05 | 974 | 160 | 16 | 28675297 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TNC PLEKHA4 SH3GLB2 PSMC5 LAMC1 AXIN2 GRIP1 UBE3A MLH1 PCYT2 LSM14A PCCB | 1.20e-05 | 560 | 160 | 12 | 21653829 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | DNAJB12 COL6A1 MYL6 PDGFRB UGGT1 IFI44 CDK11A LAMC1 CR1 PDIA3 FAT1 GANAB NID1 UGGT2 SLC39A14 CPSF2 CFAP44 GFM1 CSGALNACT1 ATP5F1A | 1.24e-05 | 1451 | 160 | 20 | 30550785 |
| Pubmed | 1.31e-05 | 167 | 160 | 7 | 22159717 | ||
| Pubmed | Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. | 1.53e-05 | 11 | 160 | 3 | 21364532 | |
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 20145200 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.59e-05 | 313 | 160 | 9 | 38270169 | |
| Pubmed | 1.64e-05 | 173 | 160 | 7 | 23979707 | ||
| Pubmed | 1.77e-05 | 175 | 160 | 7 | 28071719 | ||
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 19690384 | ||
| Pubmed | Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. | 2.04e-05 | 12 | 160 | 3 | 10611342 | |
| Pubmed | TNIK TNRC6C ADCY3 GANAB PXDN TLE4 PCDH19 DZIP3 MICAL3 SLC39A14 | 2.07e-05 | 407 | 160 | 10 | 12693553 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.10e-05 | 248 | 160 | 8 | 24006456 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28559284 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10694380 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34206051 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32081420 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27496766 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32825960 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 7524912 | ||
| Pubmed | [Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface]. | 2.10e-05 | 2 | 160 | 2 | 14619418 | |
| Pubmed | Collagens VI and XII form complexes mediating osteoblast interactions during osteogenesis. | 2.10e-05 | 2 | 160 | 2 | 26753503 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29287080 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27984238 | ||
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 2.10e-05 | 2 | 160 | 2 | 9060413 | |
| Pubmed | P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments. | 2.10e-05 | 2 | 160 | 2 | 23382862 | |
| Pubmed | Assignment of the binding site for haptoglobin on apolipoprotein A-I. | 2.10e-05 | 2 | 160 | 2 | 15533931 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12913004 | ||
| Pubmed | Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are enzymatically active. | 2.10e-05 | 2 | 160 | 2 | 24415556 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21755356 | ||
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 2.10e-05 | 2 | 160 | 2 | 10441747 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33332859 | ||
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 2.10e-05 | 2 | 160 | 2 | 16416087 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31273343 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28418868 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23674478 | ||
| Pubmed | Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface. | 2.10e-05 | 2 | 160 | 2 | 12931195 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33320095 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25926674 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24101721 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25387007 | ||
| Pubmed | Analysis of the haptoglobin binding region on the apolipoprotein A-I-derived P2a peptide. | 2.10e-05 | 2 | 160 | 2 | 23420675 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25057927 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19390571 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24140206 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22211116 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CDK16 CDK17 RPS6KA3 INSR CDK11A LAMC1 PFDN5 DYRK4 CDK14 AXIN2 TLE4 CPSF2 CDK4 | 2.17e-05 | 695 | 160 | 13 | 23602568 |
| Pubmed | 2.24e-05 | 327 | 160 | 9 | 31409639 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CMBL CUL1 RPL35A MYL6 UGGT1 PSMD2 PDIA3 GET4 GANAB LTA4H ALDH1A1 PCCB ATP5F1A MVD | 2.38e-05 | 807 | 160 | 14 | 30575818 |
| Pubmed | KRT2 COL6A1 UGGT1 LAMC1 APOA1 PDIA3 GANAB TXNDC16 GMDS ALDH1A1 | 2.54e-05 | 417 | 160 | 10 | 19199708 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 2.70e-05 | 420 | 160 | 10 | 28065597 | |
| Pubmed | TNIK CDK16 INSR FAM171B PDIA3 GRIP1 GANAB PCDH19 PLEKHA5 MICAL3 | 2.76e-05 | 421 | 160 | 10 | 36976175 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 2.95e-05 | 128 | 160 | 6 | 25332235 | |
| Pubmed | 3.12e-05 | 78 | 160 | 5 | 17192257 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK16 CDK17 MYL6 CEP290 CDH23 PSMC5 CDK11A PDIA3 PANK2 SH2D4A DZIP3 AIPL1 TRAPPC4 PLEKHA5 UGGT2 TMEM184B RSPH10B CDK4 | 4.03e-05 | 1321 | 160 | 18 | 27173435 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 CDK17 PANK3 MYO9A NAA10 LMTK2 LAMC1 DYRK4 CDK14 GRIP1 PANK2 PLEKHA5 TANC1 KIF13A | 4.80e-05 | 861 | 160 | 14 | 36931259 |
| Pubmed | 4.99e-05 | 86 | 160 | 5 | 26885983 | ||
| Pubmed | 5.12e-05 | 16 | 160 | 3 | 17567809 | ||
| Pubmed | 5.12e-05 | 16 | 160 | 3 | 16880404 | ||
| Pubmed | 5.12e-05 | 16 | 160 | 3 | 15878328 | ||
| Pubmed | 6.06e-05 | 46 | 160 | 4 | 28821611 | ||
| Pubmed | 6.15e-05 | 146 | 160 | 6 | 27068509 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 17586501 | ||
| Pubmed | CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA. | 6.29e-05 | 3 | 160 | 2 | 35002529 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 24964857 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 8245788 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 9043083 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 19758344 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 32871949 | ||
| Pubmed | Identification of a mouse male-specific transplantation antigen, H-Y. | 6.29e-05 | 3 | 160 | 2 | 7544442 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 9021139 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 14709716 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 17631502 | ||
| Interaction | PTPRO interactions | 1.94e-06 | 143 | 158 | 9 | int:PTPRO | |
| Interaction | CALR3 interactions | 1.65e-05 | 142 | 158 | 8 | int:CALR3 | |
| Interaction | PDIA4 interactions | DNAJB12 COL6A1 COL12A1 PDGFRB UGGT1 INSR LAMC1 PDIA3 TBCB GANAB MTTP TXNDC16 UGGT2 PREX1 | 1.99e-05 | 468 | 158 | 14 | int:PDIA4 |
| Interaction | HAL interactions | 2.23e-05 | 148 | 158 | 8 | int:HAL | |
| GeneFamily | Cyclin dependent kinases | 4.73e-07 | 26 | 111 | 5 | 496 | |
| GeneFamily | UDP-glucose glycoprotein glucosyltransferases | 3.74e-05 | 2 | 111 | 2 | 440 | |
| GeneFamily | Fibronectin type III domain containing | 4.61e-04 | 160 | 111 | 6 | 555 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.63e-03 | 10 | 111 | 2 | 53 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.89e-03 | 40 | 111 | 3 | 321 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 1.98e-03 | 11 | 111 | 2 | 1156 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.16e-03 | 161 | 111 | 5 | 593 | |
| GeneFamily | AT-rich interaction domain containing | 3.72e-03 | 15 | 111 | 2 | 418 | |
| Coexpression | NABA_CORE_MATRISOME | COL6A1 COL12A1 TNC LAMC1 VWDE FNDC7 PXDN HMCN1 TNN NID1 VWA3B | 8.51e-07 | 270 | 159 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL6A1 COL12A1 TNC LAMC1 VWDE FNDC7 PXDN HMCN1 TNN NID1 VWA3B | 1.02e-06 | 275 | 159 | 11 | M5884 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | TNIK CDK17 CEP290 TTC14 PLEKHA4 IFI44 CNRIP1 ATP8B2 YOD1 SAMD9L TRANK1 RNASEL TLE4 TGDS DZIP3 TANC1 TMX3 FAM118B | 1.06e-06 | 768 | 159 | 18 | M6444 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.66e-06 | 191 | 159 | 9 | MM17059 | |
| Coexpression | HSIAO_LIVER_SPECIFIC_GENES | 3.09e-06 | 249 | 159 | 10 | M13283 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.29e-06 | 196 | 159 | 9 | M3008 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | TNIK CDK17 MYOM1 IFI44 ATP8B2 SAMD9L RPS6KA6 LSM14A CSGALNACT1 | 3.88e-06 | 200 | 159 | 9 | M7495 |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 5.86e-06 | 20 | 159 | 4 | MM17053 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 6.88e-06 | 162 | 159 | 8 | M45037 | |
| Coexpression | AIZARANI_LIVER_C11_HEPATOCYTES_1 | 1.49e-05 | 298 | 159 | 10 | M39115 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_DN | 1.68e-05 | 240 | 159 | 9 | M6413 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 2.64e-05 | 195 | 159 | 8 | M1110 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.75e-05 | 29 | 159 | 4 | MM17055 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 3.17e-05 | 200 | 159 | 8 | M7518 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | 3.77e-05 | 266 | 159 | 9 | M1286 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 4.04e-05 | 207 | 159 | 8 | MM475 | |
| Coexpression | PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP | 4.41e-05 | 64 | 159 | 5 | M7488 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL6A1 SYNPO2 COL12A1 PDGFRB PLEKHA4 CNRIP1 LAMC1 LDB2 PXDN PCDH19 PPP1R16B NID1 | 6.33e-05 | 505 | 159 | 12 | M39167 |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL6A1 SYNPO2 COL12A1 PDGFRB TNC PLEKHA4 LAMC1 FAT1 HP BPIFB4 GMDS NID1 PLEKHA5 HSD11B1 SLC39A14 | 7.08e-05 | 767 | 159 | 15 | M39209 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 7.26e-05 | 225 | 159 | 8 | M6175 | |
| Coexpression | HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 8.73e-05 | 231 | 159 | 8 | M40995 | |
| Coexpression | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP | 9.09e-05 | 39 | 159 | 4 | M13339 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.01e-04 | 40 | 159 | 4 | M5887 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDK17 RPL35A RPS6KA3 TTC14 IFI44 CHD3 PFDN5 TNRC6C ARHGAP35 ATP8B2 ITPR2 TBCB PTPN6 SAMD9L TRANK1 UBE3A PPP1R15B DZIP3 PPP1R16B LSM14A FYB1 PREX1 | 1.02e-04 | 1492 | 159 | 22 | M40023 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.10e-04 | 239 | 159 | 8 | MM1274 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 1.27e-04 | 244 | 159 | 8 | M40312 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | COL6A1 PDGFRB TNC CNRIP1 HMGCS1 GJA5 PXDN PPP1R16B FYB1 PREX1 | 1.39e-04 | 389 | 159 | 10 | M4995 |
| Coexpression | GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP | 2.07e-04 | 197 | 159 | 7 | M9725 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN | 2.07e-04 | 197 | 159 | 7 | M8755 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP | 2.18e-04 | 140 | 159 | 6 | M2435 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 2.21e-04 | 199 | 159 | 7 | M8113 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP | 2.21e-04 | 199 | 159 | 7 | M8371 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP | 2.21e-04 | 199 | 159 | 7 | M7650 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 2.27e-04 | 200 | 159 | 7 | M4948 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_UP | 2.27e-04 | 200 | 159 | 7 | M8473 | |
| Coexpression | GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN | 2.27e-04 | 200 | 159 | 7 | M9791 | |
| Coexpression | GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN | 2.27e-04 | 200 | 159 | 7 | M7157 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP | 2.27e-04 | 200 | 159 | 7 | M7365 | |
| Coexpression | GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP | 2.27e-04 | 200 | 159 | 7 | M7380 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN | 2.27e-04 | 200 | 159 | 7 | M5186 | |
| Coexpression | SMITH_TERT_TARGETS_UP | 2.63e-04 | 145 | 159 | 6 | M17742 | |
| Coexpression | MACLACHLAN_BRCA1_TARGETS_UP | 2.69e-04 | 21 | 159 | 3 | M17772 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | CMBL TNIK COL12A1 PANK3 MYO9A RPS6KA3 CDK14 AXIN2 ITPR2 TRANK1 RNASEL SH2D4A HMCN1 ALDH1A1 CSGALNACT1 | 5.02e-07 | 422 | 155 | 15 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CMBL TNIK CDK16 COL6A1 COL12A1 PANK3 MYO9A RPS6KA3 CDH23 HMGCS1 CDK14 AXIN2 ITPR2 TRANK1 RNASEL SH2D4A HMCN1 TLE2 ALDH1A1 CSGALNACT1 | 1.72e-06 | 804 | 155 | 20 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | CMBL TNIK COL6A1 COL12A1 PANK3 B3GNT5 PDGFRB MYO9A HMGCS1 CDK14 LDB2 AXIN2 ITPR2 TRANK1 RNASEL SH2D4A HMCN1 ALDH1A1 CSGALNACT1 | 2.02e-06 | 740 | 155 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | COL6A1 COL12A1 PDGFRB MYO9A CDK14 AXIN2 ITPR2 TRANK1 RNASEL SH2D4A HMCN1 ALDH1A1 CSGALNACT1 | 2.30e-06 | 357 | 155 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | COL12A1 MYO9A RPS6KA3 CDK14 ITPR2 TRANK1 SH2D4A ALDH1A1 CSGALNACT1 | 3.54e-06 | 165 | 155 | 9 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_200 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | COL12A1 B3GNT5 PDGFRB MYO9A CDK14 AXIN2 ITPR2 TRANK1 RNASEL SH2D4A HMCN1 ALDH1A1 CSGALNACT1 | 5.69e-06 | 388 | 155 | 13 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | TNIK TMEM30B SYNPO2 PDGFRB CAMK4 RPS6KA3 INSR ESRP1 APOA1 TNRC6C FAM171B AXIN2 ARG1 HMCN1 TLE4 LSAMP SLC2A13 CPSF2 | 1.35e-05 | 769 | 155 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | TNIK SYNPO2 B3GNT5 MYO9A KMT5A TNRC6C KDM5D FAM171B CDK14 PGM1 LDB2 AXIN2 GRIP1 PTPN6 FAT1 HMCN1 TLE2 TLE4 PCDH19 RPS6KA6 SLC2A13 ALDH1A1 SLC39A14 | 2.29e-05 | 1208 | 155 | 23 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | COL6A1 SYNPO2 PDGFRB TNC LAMC1 CDK14 FAT1 PXDN PCDH19 NID1 ALDH1A1 TPPP3 HSD11B1 | 2.43e-05 | 445 | 155 | 13 | GSM777043_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 2.46e-05 | 161 | 155 | 8 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.06e-05 | 166 | 155 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | ZBTB17 PANK3 TNC CEP290 KDM5D LDB2 GRIP1 GJA5 PANK2 HMCN1 PCDH19 BPIFB4 RPS6KA6 TXNDC16 UGGT2 MICAL3 TANC1 SLC2A13 KIF13A FYB1 | 3.38e-05 | 985 | 155 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | TNIK COL6A1 B3GNT5 PDGFRB MYO9A TNC KDM5D ATP8B2 LDB2 FAT1 TRANK1 PXDN HMCN1 DZIP3 NID1 ALDH1A1 TMX3 | 4.79e-05 | 768 | 155 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 4.84e-05 | 89 | 155 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | CMBL COL12A1 PANK3 MYO9A RPS6KA3 CDK14 ITPR2 TRANK1 SH2D4A HMCN1 ALDH1A1 CSGALNACT1 | 5.44e-05 | 414 | 155 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 6.59e-05 | 94 | 155 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | TNIK CAMK4 RPS6KA3 TNRC6C FAM171B AXIN2 HMCN1 TLE4 LSAMP SLC2A13 CPSF2 | 1.06e-04 | 377 | 155 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | COL6A1 SYNPO2 PDGFRB TNC LAMC1 CDK14 FAT1 PXDN HMCN1 NID1 ALDH1A1 TPPP3 | 1.66e-04 | 466 | 155 | 12 | GSM777050_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 1.86e-04 | 336 | 155 | 10 | GSM538413_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | COL6A1 COL12A1 PANK3 B3GNT5 PDGFRB MYO9A RPS6KA3 CDK14 AXIN2 ITPR2 TRANK1 RNASEL SH2D4A HMCN1 ALDH1A1 CSGALNACT1 | 2.02e-04 | 783 | 155 | 16 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.12e-04 | 219 | 155 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CMBL TNIK CDK16 COL12A1 PANK3 MYO9A RPS6KA3 CDK14 AXIN2 ITPR2 TRANK1 RNASEL SH2D4A HMCN1 ALDH1A1 CSGALNACT1 | 2.68e-04 | 803 | 155 | 16 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | CDK17 CAMK4 INSR LAMC1 LDB2 ITPR2 GJA5 SAMD9L PXDN HMCN1 PPP1R16B NID1 TMEM184B FYB1 PREX1 CSGALNACT1 | 3.91e-04 | 831 | 155 | 16 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200 | 3.97e-04 | 20 | 155 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_200 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO2 COL12A1 PDGFRB TNC CAMK4 ADCY3 LDB2 LOXHD1 PXDN NID1 LSAMP | 1.43e-10 | 196 | 160 | 11 | a12dd986df65c36f248cf10815c3b8b6238613b0 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO2 COL12A1 PDGFRB TNC CAMK4 ADCY3 LDB2 LOXHD1 PXDN NID1 LSAMP | 1.43e-10 | 196 | 160 | 11 | 3e6803587d8566fd08cb8b290be3b6461743d79c |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO2 COL12A1 PDGFRB TNC CAMK4 ADCY3 LDB2 LOXHD1 PXDN NID1 LSAMP | 1.51e-10 | 197 | 160 | 11 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-09 | 191 | 160 | 10 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-09 | 192 | 160 | 10 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-09 | 192 | 160 | 10 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO2 COL12A1 PDGFRB TNC CAMK4 ADCY3 LDB2 LOXHD1 NID1 LSAMP | 2.17e-09 | 193 | 160 | 10 | f1199518c3626fd29bfce65070dd21a660671213 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO2 COL12A1 PDGFRB TNC CAMK4 LDB2 LOXHD1 NID1 LSAMP HSD11B1 | 2.52e-09 | 196 | 160 | 10 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SYNPO2 COL12A1 PDGFRB TNC CAMK4 LDB2 LOXHD1 NID1 LSAMP HSD11B1 | 2.52e-09 | 196 | 160 | 10 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.12e-08 | 182 | 160 | 9 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-08 | 187 | 160 | 9 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-08 | 187 | 160 | 9 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-08 | 187 | 160 | 9 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-08 | 190 | 160 | 9 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-08 | 190 | 160 | 9 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.36e-08 | 192 | 160 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-08 | 194 | 160 | 9 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-08 | 194 | 160 | 9 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-08 | 195 | 160 | 9 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-08 | 195 | 160 | 9 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-08 | 195 | 160 | 9 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-08 | 195 | 160 | 9 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-08 | 197 | 160 | 9 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-08 | 197 | 160 | 9 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-07 | 180 | 160 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-07 | 180 | 160 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-07 | 182 | 160 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-07 | 183 | 160 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-07 | 183 | 160 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-07 | 183 | 160 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.99e-07 | 187 | 160 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.07e-07 | 193 | 160 | 8 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-07 | 194 | 160 | 8 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 5.27e-07 | 194 | 160 | 8 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-07 | 194 | 160 | 8 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-07 | 194 | 160 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-07 | 195 | 160 | 8 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-07 | 195 | 160 | 8 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.48e-07 | 195 | 160 | 8 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-07 | 195 | 160 | 8 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-07 | 195 | 160 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-07 | 196 | 160 | 8 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.92e-07 | 197 | 160 | 8 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-07 | 197 | 160 | 8 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.15e-07 | 198 | 160 | 8 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.15e-07 | 198 | 160 | 8 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.15e-07 | 198 | 160 | 8 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.15e-07 | 198 | 160 | 8 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.39e-07 | 199 | 160 | 8 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-07 | 199 | 160 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.39e-07 | 199 | 160 | 8 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 200 | 160 | 8 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.63e-07 | 200 | 160 | 8 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.63e-07 | 200 | 160 | 8 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.63e-07 | 200 | 160 | 8 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.71e-06 | 158 | 160 | 7 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | normal-na-Hematopoietic-Progen-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.13e-06 | 173 | 160 | 7 | e666364eb110c1c976e5b09a632dd1454513f131 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-06 | 180 | 160 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-06 | 181 | 160 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.37e-06 | 182 | 160 | 7 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.37e-06 | 182 | 160 | 7 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-06 | 182 | 160 | 7 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-06 | 182 | 160 | 7 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-06 | 183 | 160 | 7 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.53e-06 | 183 | 160 | 7 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-06 | 183 | 160 | 7 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.53e-06 | 183 | 160 | 7 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.87e-06 | 185 | 160 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 187 | 160 | 7 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-06 | 187 | 160 | 7 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 187 | 160 | 7 | 1387981d224cb9e846ed18e366736855a4eb827e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-06 | 188 | 160 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-06 | 189 | 160 | 7 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 5.60e-06 | 189 | 160 | 7 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.60e-06 | 189 | 160 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 5.80e-06 | 190 | 160 | 7 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.80e-06 | 190 | 160 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-06 | 191 | 160 | 7 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-06 | 191 | 160 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.00e-06 | 191 | 160 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 6.00e-06 | 191 | 160 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-06 | 191 | 160 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.00e-06 | 191 | 160 | 7 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-06 | 191 | 160 | 7 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-06 | 193 | 160 | 7 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-06 | 193 | 160 | 7 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 6.43e-06 | 193 | 160 | 7 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-06 | 193 | 160 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.43e-06 | 193 | 160 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Control-Classical_Monocyte|Control / Disease condition and Cell class | 6.65e-06 | 194 | 160 | 7 | 9e33e1b54b4114f9e6981819834bb796ed7192b5 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.65e-06 | 194 | 160 | 7 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 194 | 160 | 7 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.65e-06 | 194 | 160 | 7 | cb9f67366cfa39bd7dfd3b7a6e4672af93350958 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 6.87e-06 | 195 | 160 | 7 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-06 | 195 | 160 | 7 | 6d60a364b8c5c3384a430b858435f5cc542d80e3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 195 | 160 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.87e-06 | 195 | 160 | 7 | 662b50a2aa97373bf343b88caace9717049c722a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 195 | 160 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-06 | 196 | 160 | 7 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.34e-05 | 206 | 154 | 8 | C0152013 | |
| Disease | hair colour measurement | TNIK DNAJB12 ZBTB17 KMT5A CDK14 AXIN2 PXDN TLE4 TGDS GMDS CPSF2 CSGALNACT1 MVD | 2.21e-05 | 615 | 154 | 13 | EFO_0007822 |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 7.43e-05 | 16 | 154 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Diabetic Angiopathies | 7.43e-05 | 16 | 154 | 3 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 7.43e-05 | 16 | 154 | 3 | C0025945 | |
| Disease | Spastic tetraparesis | 8.09e-05 | 3 | 154 | 2 | C0575059 | |
| Disease | height-adjusted body mass index | 8.09e-05 | 3 | 154 | 2 | EFO_0005851 | |
| Disease | Gastric Adenocarcinoma | 9.00e-05 | 45 | 154 | 4 | C0278701 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.52e-04 | 152 | 154 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | arabitol measurement, xylitol measurement | 1.61e-04 | 4 | 154 | 2 | EFO_0800148, EFO_0801067 | |
| Disease | Ullrich congenital muscular dystrophy | 1.61e-04 | 4 | 154 | 2 | cv:C4551860 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Bethlem myopathy | 1.61e-04 | 4 | 154 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.61e-04 | 4 | 154 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.61e-04 | 4 | 154 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.61e-04 | 4 | 154 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.61e-04 | 4 | 154 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | pantothenate kinase-associated neurodegeneration (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:3981 (implicated_via_orthology) | |
| Disease | monoclonal gammopathy | 1.71e-04 | 53 | 154 | 4 | EFO_0000203 | |
| Disease | pre-eclampsia (is_implicated_in) | 2.95e-04 | 25 | 154 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | orofacial cleft (is_implicated_in) | 5.59e-04 | 7 | 154 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | COVID-19, obesity | 5.59e-04 | 7 | 154 | 2 | EFO_0001073, MONDO_0100096 | |
| Disease | neuronal pentraxin-2 measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0801834 | |
| Disease | Large cell carcinoma of lung | 6.19e-04 | 32 | 154 | 3 | C0345958 | |
| Disease | cytomegalovirus infection, response to allogeneic hematopoietic stem cell transplant | 7.42e-04 | 8 | 154 | 2 | EFO_0001062, EFO_0007044 | |
| Disease | Disorder of eye | 8.91e-04 | 212 | 154 | 6 | C0015397 | |
| Disease | liver cirrhosis (is_marker_for) | 9.10e-04 | 82 | 154 | 4 | DOID:5082 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.06e-03 | 301 | 154 | 7 | DOID:684 (is_marker_for) | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.18e-03 | 10 | 154 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | glucagon-like peptide-1 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0008465 | |
| Disease | Lymphoma | 1.20e-03 | 40 | 154 | 3 | C0024299 | |
| Disease | hypertension (biomarker_via_orthology) | 1.27e-03 | 227 | 154 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 1.38e-03 | 42 | 154 | 3 | DOID:8991 (is_marker_for) | |
| Disease | diffusing capacity of the lung for carbon monoxide | 1.63e-03 | 96 | 154 | 4 | EFO_0009369 | |
| Disease | beta-endorphin measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0008034 | |
| Disease | hearing impairment | 1.76e-03 | 98 | 154 | 4 | C1384666 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 1.80e-03 | 46 | 154 | 3 | EFO_0008003, GO_0097332 | |
| Disease | eosinophil measurement | 2.51e-03 | 108 | 154 | 4 | EFO_0803540 | |
| Disease | visceral:abdominal adipose tissue ratio measurement | 2.55e-03 | 52 | 154 | 3 | EFO_0803318 | |
| Disease | Liver Cirrhosis, Experimental | COL6A1 COL12A1 PDGFRB FAT1 RNASEL PXDN NID1 LTA4H ALDH1A1 TMEM184B CSGALNACT1 | 2.55e-03 | 774 | 154 | 11 | C0023893 |
| Disease | inflammatory bowel disease | 2.56e-03 | 449 | 154 | 8 | EFO_0003767 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.68e-03 | 110 | 154 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.68e-03 | 110 | 154 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | hepatoblastoma (is_marker_for) | 2.72e-03 | 15 | 154 | 2 | DOID:687 (is_marker_for) | |
| Disease | Antihypertensive use measurement | 2.75e-03 | 265 | 154 | 6 | EFO_0009927 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 3.10e-03 | 16 | 154 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | Leber congenital amaurosis | 3.10e-03 | 16 | 154 | 2 | cv:C0339527 | |
| Disease | Drug habituation | 3.15e-03 | 115 | 154 | 4 | C0013170 | |
| Disease | Drug abuse | 3.15e-03 | 115 | 154 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.15e-03 | 115 | 154 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 3.15e-03 | 115 | 154 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 3.15e-03 | 115 | 154 | 4 | C0013222 | |
| Disease | Drug Dependence | 3.15e-03 | 115 | 154 | 4 | C1510472 | |
| Disease | Substance Dependence | 3.15e-03 | 115 | 154 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 3.15e-03 | 115 | 154 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.15e-03 | 115 | 154 | 4 | C0029231 | |
| Disease | Substance abuse problem | 3.25e-03 | 116 | 154 | 4 | C0740858 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0008270 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0021049 | |
| Disease | colorectal health | 4.16e-03 | 201 | 154 | 5 | EFO_0008460 | |
| Disease | smooth surface dental caries | 4.21e-03 | 62 | 154 | 3 | EFO_0006339 | |
| Disease | Hypertriglyceridemia | 4.37e-03 | 19 | 154 | 2 | EFO_0004211 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 4.37e-03 | 19 | 154 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | unipolar depression, response to bupropion, mood disorder | 4.37e-03 | 19 | 154 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | age at onset, smoking initiation | 4.37e-03 | 19 | 154 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | renal cell carcinoma (is_marker_for) | 4.61e-03 | 128 | 154 | 4 | DOID:4450 (is_marker_for) | |
| Disease | Malaria | 4.83e-03 | 20 | 154 | 2 | C0024530 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGSGLRQYYLSKIEE | 16 | P62195 | |
| AGLEAGVLYRVKTSY | 366 | Q5DID0 | |
| AFDYRGEIYVKGISE | 1146 | P40145 | |
| EYLKRYLSGADAGVD | 11 | Q9BRD0 | |
| LGRYEEASSKYQEAI | 191 | Q9NZN9 | |
| EGIYRTERDKGTLYE | 211 | Q8TDX6 | |
| IKARVTYIDYEGRSD | 531 | Q9P2I0 | |
| TYIDYEGRSDGDSIK | 536 | Q9P2I0 | |
| AYVYLDSEVTGLDTR | 211 | Q96QU6 | |
| GKYRYGEILESEGSI | 101 | P59827 | |
| LTSDIYLEYVRSGGE | 191 | Q9Y2T1 | |
| RELGEYGFHEYTEVK | 476 | P00352 | |
| SRVIYAKLGGEILDY | 296 | Q6H8Q1 | |
| VYVDVLKDSGRDYVS | 41 | P02647 | |
| EKLEKLGEGSYATVY | 136 | O94921 | |
| IKGGALRQEEVYYDS | 246 | P28845 | |
| YLDGIITIVDSKYGL | 161 | Q5RIA9 | |
| DISLYEGYGVISVSR | 611 | Q9H251 | |
| RVLRDGTEKGYAYVD | 221 | Q96MT7 | |
| AVIYAGVRGYLDKLE | 486 | P25705 | |
| EGLYITEEIYKTGLL | 256 | P05089 | |
| EYAGEGLRTLVLAYK | 606 | P98198 | |
| VYAVVYGAGKERLAA | 681 | Q7Z5Q5 | |
| GTRYIEVYKATGEDF | 291 | Q6NXG1 | |
| LEKYDGVDAGKYTIG | 36 | Q01581 | |
| GATIRLYIDSYEKDV | 511 | P36871 | |
| ISYGGADYKRITVKV | 116 | Q9NZQ7 | |
| YSSYREDVLKGGDVV | 226 | Q14571 | |
| YYKLVTDGALDREQT | 401 | Q9Y5F9 | |
| VYDDGTKVVYEVRSG | 171 | Q8IXS6 | |
| EDAGYTKRVLLIYDG | 251 | Q5VVQ6 | |
| SDVGYDRFVLYKEGE | 246 | Q8N149 | |
| EVKYALGERQSYKGS | 71 | P09960 | |
| SGIGYLVTVVKAEDY | 581 | Q8TAB3 | |
| LIVESYEGEKVRGLY | 81 | P0C881 | |
| LIVESYEGEKVRGLY | 81 | B2RC85 | |
| SYKGRVYESAAVGSV | 1566 | Q14517 | |
| RTCELARVEDGKGYY | 81 | P31275 | |
| TTLRLSAYAYDIEDG | 796 | Q7RTP6 | |
| YKLRTEGDGVYTLND | 56 | P00738 | |
| EELLYDYGDRSKASI | 371 | Q9NQR1 | |
| GSYLAEFLLEKGYEV | 36 | O60547 | |
| VEKGYYSERDAADAV | 131 | Q16566 | |
| RGAELYETKAVDGYN | 396 | Q5VTL7 | |
| GYEVKEDIGVGSYSV | 421 | P51812 | |
| GYIDSLKRYLDGLTA | 231 | P35908 | |
| IAVTSRGYYGLEDEK | 206 | Q5HYC2 | |
| YTDILDIYEGVGSSK | 276 | P98073 | |
| DLYSLSKIVIEEGGY | 111 | Q9BY66 | |
| TVFEGGVTDLYYILK | 91 | O43679 | |
| DAKVYITIYGDLGDT | 1271 | Q8IVV2 | |
| YLDGIITIVDSKYGL | 161 | Q8IUF1 | |
| YLDGIITIVDSKYGL | 161 | Q9BRT8 | |
| YSDTLELVVTGLYGK | 111 | P24071 | |
| KDQGTYEDYVEGLRV | 81 | P60660 | |
| VGTGYYVEKTAEDAK | 86 | Q99471 | |
| DGRDTYEEVKQAGRY | 121 | Q99447 | |
| YVYLKDGDVIKTEGA | 121 | Q53H82 | |
| EKKYERLSTGRGYVS | 841 | P55157 | |
| LSYIAEDENGKIVGY | 41 | P41227 | |
| LDTTDGLGKVYYRED | 111 | P14543 | |
| RGSYGYIKTTAVEID | 556 | O15117 | |
| VSDVGYDRFVLYKEG | 246 | Q8N423 | |
| YTLARVYGVESDLSE | 136 | P53602 | |
| SVGSDYYIQLEEKSG | 546 | Q8IWU2 | |
| SKAEIRYEGILYTID | 16 | Q8ND56 | |
| YELKEDIGVGSYSVC | 426 | Q9UK32 | |
| EKLGEGTYATVYKGR | 196 | Q00537 | |
| DERRTYGAKSDIIYV | 601 | P06213 | |
| YLVTKVVAVDADSGY | 586 | Q9Y5G1 | |
| YGVALTERGKKEDYT | 141 | Q86Y13 | |
| LTISRIEAGDEADYY | 91 | A0A075B6K2 | |
| IGYKVYEEIASTSSG | 181 | Q96RW7 | |
| ADKLVRDIYGGDYER | 246 | Q9H999 | |
| KVTVITRKAYGGAYD | 426 | P05166 | |
| VDKLVRDIYGGDYER | 446 | Q9BZ23 | |
| LSDRTNLYRKEYEGE | 351 | Q96T49 | |
| AAYVISGDVAAKVYE | 256 | Q9BYG0 | |
| AYRYEVLETIGKGSF | 101 | Q9NR20 | |
| GISEKYRTYSIRDGK | 226 | Q8TCB0 | |
| DGLLYVVAADSTERY | 381 | Q9UJP4 | |
| SLYLGKEEYLGSVDT | 206 | Q9BX69 | |
| VGDYIGIYASIKTDS | 211 | Q9BXJ0 | |
| LVTGKTAEYDVAYGE | 986 | P12109 | |
| GDYVTLKCEDGYTLE | 1931 | P17927 | |
| YKITVIAVYEDGDGG | 2091 | Q99715 | |
| IKLDKLGEGTYATVY | 166 | Q00536 | |
| EIGVGAYGTVYKARD | 11 | P11802 | |
| KRLKDYESGVYGLED | 446 | O15078 | |
| RDEYREKSESGGSEY | 81 | Q12873 | |
| EGRKGIYEIYSLALV | 151 | Q13616 | |
| AERAKEVRGSGSYEY | 111 | P36382 | |
| EVRGSGSYEYPVAEK | 116 | P36382 | |
| KEPDGDRVVYTGTYD | 76 | Q96F85 | |
| YYEILGVSRGASDED | 111 | Q9NXW2 | |
| SSNGIKELEYDYTGD | 56 | Q3MIR4 | |
| YLDGIITIVDSKYGL | 161 | Q5JTY5 | |
| YLDGIITIVDSKYGL | 161 | Q4V339 | |
| GSRCDYLEEKGIETY | 476 | O60266 | |
| RIEEGTYGVVYRAKD | 431 | Q9UQ88 | |
| KGIKVISYGDDYADL | 296 | Q9BPY3 | |
| IRGTYSERSAGYLDD | 656 | P11047 | |
| FTYEIRLVEDGKYGA | 476 | Q13002 | |
| SSGAIIYTVELKRYG | 666 | Q9Y3R0 | |
| YSIQEGSGKREEKTY | 376 | Q96MH7 | |
| VRSYQGELKKGDTIY | 371 | Q96RP9 | |
| RKEYYALGSLRESEE | 456 | Q9P1V8 | |
| LEDYYVSKSAVVFGG | 216 | Q15043 | |
| SVGYLSLLDADYDRK | 1656 | Q8TDX9 | |
| EKRYLTGNEEAYGRS | 511 | Q6P995 | |
| YEKIGTLSCEIDAYG | 301 | O14772 | |
| KTTIGDREVDSDAYY | 191 | P09619 | |
| RYYGGTEFIDELETL | 81 | P34896 | |
| TSDGETYIEKYTRGV | 1336 | Q9H1H9 | |
| SDEGRYIEYIRVKGS | 621 | Q96QE2 | |
| EGVYARDETEFYLGK | 31 | P18077 | |
| GKSSIDDSYGRYDLI | 1336 | Q9HCJ0 | |
| VNGRYTADGKEVLEY | 71 | Q9Y296 | |
| VEKLQDLDTDYGSGY | 196 | O75792 | |
| RDGDFDVTSGYLYVT | 201 | Q9Y519 | |
| GIRYSKLSEGASYLD | 116 | P12259 | |
| VEGKLRASVEKGDYY | 26 | Q7L5D6 | |
| YLEILGITREQSGKY | 181 | Q13449 | |
| YYKDSREESVLGSVL | 86 | Q9H4M7 | |
| DVDGGLTQIDKYLYS | 421 | Q13200 | |
| LIKTEVAEYGRYTGV | 971 | Q8IVG5 | |
| KYEGGRELSDFISYL | 466 | P30101 | |
| LGLYVKTRDGSDYEG | 486 | Q14697 | |
| YDDGTYKARSELEDI | 496 | Q8TCU6 | |
| DEKYKIADTSEGGIY | 366 | Q05823 | |
| GTRKARVLYDYEAAD | 336 | Q9NR46 | |
| LYYDVSTARDVLESG | 66 | P03979 | |
| YGDAETVLYLVEKGA | 1221 | Q9C0D5 | |
| EEYGKILEVVGRYSV | 171 | P40692 | |
| EVTEYYISGDEDRKG | 646 | Q5SWA1 | |
| YIEATGLSTEGIYRV | 1271 | Q9NRY4 | |
| GVSVYGIVKDSEDIY | 151 | Q96DG6 | |
| KFIYVSTDEVYGGSL | 136 | O95455 | |
| TDGGYIEERYEVSKS | 401 | Q96JJ7 | |
| ISEDGKEYYLRIEST | 301 | Q8N2E2 | |
| EGVYVNTYGRITKDV | 1261 | Q9UKE5 | |
| LKGYVITGIYSEEDV | 551 | Q9P2K2 | |
| YDGGYTRDSVLIREF | 776 | Q05086 | |
| KYTLVSYGTGELERE | 406 | Q9UMS6 | |
| AIDKYVVRYTSAGGE | 646 | Q9UQP3 | |
| YIVTGSGDKKATVYE | 756 | Q04727 | |
| GEYEDVSRVEKYTIS | 96 | Q99426 | |
| GDTIYYETRKIVGAE | 1011 | Q92626 | |
| REATEYEIELYGISK | 1681 | P24821 | |
| GYLLVYESVDGTVKE | 1916 | P24821 | |
| GRVYVYNGKETTLGD | 756 | P80108 | |
| ERIKGYALSYLSEDG | 376 | Q9H788 | |
| SYYQTGDIIRAGIKD | 181 | Q96N46 | |
| LKDTVYTDFDGTRVY | 196 | Q86V86 | |
| YDLYGGEKFATLTEL | 61 | P29350 | |
| RQDILDDSGYVSAYK | 151 | Q9BW30 | |
| TYGDRTESKAYGSVI | 291 | Q13105 | |
| LLEAGRDKTIESIYY | 226 | Q502W6 | |
| GYGVELAIKSTEYKA | 231 | Q9NYU1 | |
| TKGSIVRGLYYEEVR | 2611 | O15050 | |
| YYRDEKEEGILGSIL | 201 | Q9HAU0 | |
| RTTGAKYGDVDDAVY | 71 | Q6NT04 | |
| YIVTGSGDKKATVYE | 726 | Q04725 | |
| EANRIYYLTVKSGEE | 431 | Q15849 | |
| YYALGQATGLDEEKR | 86 | Q07283 | |
| LSGYGVELAIKSTEY | 241 | Q9NYU2 | |
| LYEEIGRGSKTVVYK | 6 | Q96C45 | |
| DLYSLSKIVVEEGGY | 111 | P41229 | |
| ETGTVLGAYVEKYLL | 306 | B2RTY4 | |
| KELVGYYIEASVAGS | 766 | P52179 |